Interuniversity Institute of Myology. 2026. “23 | Preclinical Evaluation of 3s-HMGB1 As a Therapeutic Strategy for Duchenne Muscular Dystrophy: Federica Esposito1, E. Sbolli1, S. Curtarello1, E. Ruggieri1|2, M. Patrone1|2, M. Rodrigues3, V. Taglietti3, F. Relaix3, E. Vénéreau1|2 | 1Unit, Division of Genetics and Cellular Biology, IRCCS Ospedale San Raffaele, Milan, Italy; 2University Vita-Salute San Raffaele, Milan, Italy; 3Univ Paris-Est Créteil, INSERM, U955 IMRB, Créteil, France”. European Journal of Translational Myology 36 (s2). https://doi.org/10.4081/ejtm.2026.15471.